Schedule 13D ownership disclosure

Armata Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 04216R102

Event date: 2022-03-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
80.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-22-000437
Form type
SC 13D/A
Filer
Armata Pharmaceuticals, Inc.
CIK
CIK 921114
Filed
Apr 01, 2022
Reporting period
Mar 31, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub